- Home
- APGE vs OUT Comparison
APGE vs OUT Comparison
Compare APGE & OUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | APGE | OUT |
|---|---|---|
| Founded | 2022 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 5.5B |
| IPO Year | 2023 | 2013 |
Fundamental Metrics
Financial Performance| Metric | APGE | OUT |
|---|---|---|
| Price | $132.71 | $31.97 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 6 |
| Target Price | ★ $109.67 | $28.50 |
| AVG Volume (30 Days) | ★ 4.0M | 1.7M |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 3.94% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.11 |
| Revenue | N/A | ★ $1,831,700,000.00 |
| Revenue This Year | N/A | $6.19 |
| Revenue Next Year | N/A | $3.08 |
| P/E Ratio | ★ N/A | $292.27 |
| Revenue Growth | N/A | ★ 0.04 |
| 52 Week Low | $34.34 | $15.90 |
| 52 Week High | $133.16 | $34.96 |
Technical Indicators
Market Signals| Indicator | APGE | OUT |
|---|---|---|
| Relative Strength Index (RSI) | 81.42 | 57.00 |
| Support Level | $75.41 | $31.14 |
| Resistance Level | N/A | $33.94 |
| Average True Range (ATR) | 4.21 | 0.84 |
| MACD | 5.57 | 0.05 |
| Stochastic Oscillator | 99.15 | 85.35 |
Price Performance
Historical ComparisonAbout APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
About OUT OUTFRONT Media Inc.
Outfront Media Inc is a real estate investment trust involved in the ownership of advertising space on its portfolio of billboards and transit displays. The company has two reportable operating segments: Billboard and Transit. It derives maximum revenue from Billboard Segment. The company geographically operates in United States and Canada, of which United States derive maximum revenue.